Neurometrix Stock Price To Earning

NURO Stock  USD 4.25  0.03  0.71%   
NeuroMetrix fundamentals help investors to digest information that contributes to NeuroMetrix's financial success or failures. It also enables traders to predict the movement of NeuroMetrix Stock. The fundamental analysis module provides a way to measure NeuroMetrix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NeuroMetrix stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

NeuroMetrix Company Price To Earning Analysis

NeuroMetrix's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current NeuroMetrix Price To Earning

    
  6.51 X  
Most of NeuroMetrix's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NeuroMetrix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

NeuroMetrix Price To Earning Driver Correlations

Understanding the fundamental principles of building solid financial models for NeuroMetrix is extremely important. It helps to project a fair market value of NeuroMetrix Stock properly, considering its historical fundamentals such as Price To Earning. Since NeuroMetrix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of NeuroMetrix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of NeuroMetrix's interrelated accounts and indicators.
0.7-0.03-0.37-0.45-0.17-0.24-0.381.00.050.260.20.390.880.470.930.93-0.07
0.70.04-0.32-0.810.11-0.31-0.930.740.230.340.15-0.170.530.490.570.57-0.18
-0.030.040.2-0.340.580.56-0.07-0.030.550.160.89-0.03-0.010.420.00.0-0.01
-0.37-0.320.2-0.05-0.110.210.2-0.40.11-0.45-0.070.51-0.060.25-0.2-0.2-0.45
-0.45-0.81-0.34-0.05-0.160.270.82-0.47-0.62-0.19-0.240.07-0.45-0.8-0.46-0.460.5
-0.170.110.58-0.11-0.160.65-0.22-0.140.20.330.65-0.51-0.380.0-0.37-0.370.3
-0.24-0.310.560.210.270.650.27-0.24-0.010.030.52-0.05-0.34-0.17-0.34-0.340.47
-0.38-0.93-0.070.20.82-0.220.27-0.43-0.27-0.28-0.080.4-0.24-0.4-0.25-0.250.21
1.00.74-0.03-0.4-0.47-0.14-0.24-0.430.050.310.210.330.850.450.910.91-0.04
0.050.230.550.11-0.620.2-0.01-0.270.05-0.030.33-0.140.030.730.180.18-0.41
0.260.340.16-0.45-0.190.330.03-0.280.31-0.030.36-0.34-0.08-0.090.190.20.57
0.20.150.89-0.07-0.240.650.52-0.080.210.330.36-0.030.10.280.120.120.16
0.39-0.17-0.030.510.07-0.51-0.050.40.33-0.14-0.34-0.030.660.30.530.53-0.33
0.880.53-0.01-0.06-0.45-0.38-0.34-0.240.850.03-0.080.10.660.570.890.89-0.39
0.470.490.420.25-0.80.0-0.17-0.40.450.73-0.090.280.30.570.60.6-0.63
0.930.570.0-0.2-0.46-0.37-0.34-0.250.910.180.190.120.530.890.61.0-0.19
0.930.570.0-0.2-0.46-0.37-0.34-0.250.910.180.20.120.530.890.61.0-0.19
-0.07-0.18-0.01-0.450.50.30.470.21-0.04-0.410.570.16-0.33-0.39-0.63-0.19-0.19
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

NeuroMetrix Retained Earnings

Retained Earnings

(220.61 Million)

NeuroMetrix reported last year Retained Earnings of (210.11 Million)
Based on the latest financial disclosure, NeuroMetrix has a Price To Earning of 6.51 times. This is 74.81% lower than that of the Health Care Equipment & Supplies sector and 90.68% lower than that of the Health Care industry. The price to earning for all United States stocks is 77.33% higher than that of the company.

NeuroMetrix Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NeuroMetrix's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NeuroMetrix could also be used in its relative valuation, which is a method of valuing NeuroMetrix by comparing valuation metrics of similar companies.
NeuroMetrix is currently under evaluation in price to earning category among its peers.

NeuroMetrix ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, NeuroMetrix's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to NeuroMetrix's managers, analysts, and investors.
Environmental
Governance
Social

NeuroMetrix Fundamentals

About NeuroMetrix Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze NeuroMetrix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeuroMetrix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeuroMetrix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with NeuroMetrix

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeuroMetrix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroMetrix will appreciate offsetting losses from the drop in the long position's value.

Moving against NeuroMetrix Stock

  0.57ENOV Enovis CorpPairCorr
  0.38IVP Inspire VeterinaryPairCorr
The ability to find closely correlated positions to NeuroMetrix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeuroMetrix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeuroMetrix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeuroMetrix to buy it.
The correlation of NeuroMetrix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeuroMetrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeuroMetrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeuroMetrix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether NeuroMetrix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeuroMetrix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurometrix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurometrix Stock:
Check out NeuroMetrix Piotroski F Score and NeuroMetrix Altman Z Score analysis.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.51)
Revenue Per Share
2.157
Quarterly Revenue Growth
(0.51)
Return On Assets
(0.28)
Return On Equity
(0.43)
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.